Rybelsus (Semaglutide)


Note : Image for illustrative purposes only

Rybelsus (Semaglutide)

  • Currently being used 'off-label' for weight loss
  • Not licensed for weight loss
  • Pricing is only showed for information purposes
  • This page is for informational purposes only
  • It's the prescribers decision to issue a prescription
From £0.00


Buy Rybelsus - Much like it's former injection form (Ozempic), RYBELSUS® works in three main ways.

Produced by Novo Nordisk, The medication mimics a natural hormone already found in your body (GLP-1). It works in three key ways to reduce your appetite.


  1. It regulates the key hunger hormone GLP-1, effectively reducing your appetite.

  2. It slows down the gastric emptying process, meaning that your body takes longer to process food and it is fuller for longer. This means your body does not need as much intake as normal as it works off the food it has.

  3. The medication helps to speed up your metabolism by helping the liver utilise an enzyme to break down glycogen in a safe and controlled method.


This all helps to reduce the risk of the so-called "starvation mode" and other side effects like ketoacidosis, as you will be burning off a mixture of stored carbs & fats.


Unlike fad diets which tend to starve the body when it's shouting out for food, the medication reduces your body's desire to get more food, which makes it easier to make healthier choices and to reduce calories.


This means that when you stop using the medication, the body isn't desperate for sustenance and therefore, you won't suddenly begin storing fat and gain all the weight back. Ironically, it's a more natural way to lose the weight and keep it off.


You can opt for Wegovy UK which is the injection of these tablets that has been approved by the FDA and MHRA for use in weight loss.

Indications and Usage

RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.



  • RYBELSUS® is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in patients with known hypersensitivity to semaglutide or to any of the components in RYBELSUS®


Adverse Reactions

  • The most common adverse reactions, reported in ≥5% of patients treated with RYBELSUS® are nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation


Buy Rybelsus | Buy Rybelsus | Buy Rybelsus | Buy Rybelsus 

You have to be authenticated to write a review